Evofem Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Evofem Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014083
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for contraception, itching, burning and stinging, fine lines, wrinkles, skin tone, texture, color and elasticity. The company concentrates on women’s health and reproductive care, contraception, and the prevention of STI. It partners with WomanCare Global to market its products. Evofem is headquartered in San Diego, California, the US.

Evofem Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evofem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evofem Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evofem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evofem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Evofem Inc, Medical Devices Deals, 2011 to YTD 2017 9
Evofem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Evofem Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Partnerships 14
Evofem Enters into Agreement with DKT International 14
Merger 15
Neothetics and Evofem Biosciences to Merge 15
Equity Offering 17
Evofem Raises USD25 Million in Private Placement of Shares 17
Evofem Inc – Key Competitors 18
Evofem Inc – Key Employees 19
Evofem Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Dec 16, 2016: Evofem Biosciences Appoints Dr. David Friend as Chief Scientific Officer 21
Aug 29, 2016: Evofem Biosciences Appoints Russell Barrans as Chief Commercial Officer 22
Product Approvals 23
Mar 31, 2016: Evofem Files IND for Evaluation of Prevention of Recurrence of Bacterial Vaginosis 23
Jan 11, 2016: Evofem Holdings Announces Successful Completion of Pre-IND Meeting for Amphora 24
Clinical Trials 25
Aug 17, 2016: Evofem Announces First Patient Enrolled in a Clinical Trial to Determine the Effect and Duration of Amphora Gel on Vaginal pH 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Evofem Inc, Pharmaceuticals & Healthcare, Key Facts 2
Evofem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evofem Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evofem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evofem Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Evofem Inc, Medical Devices Deals, 2011 to YTD 2017 9
Evofem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Evofem Biosciences Raises USD7.5 Million Venture Financing 11
Evofem Holdings Raises USD20.5 Million in Venture Financing 12
Evofem Raises USD20 Million in Financing Round 13
Evofem Enters into Agreement with DKT International 14
Neothetics and Evofem Biosciences to Merge 15
Evofem Raises USD25 Million in Private Placement of Shares 17
Evofem Inc, Key Competitors 18
Evofem Inc, Key Employees 19

★海外企業調査レポート[Evofem Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Bunzl plc:企業の戦略・SWOT・財務分析
    Bunzl plc - Strategy, SWOT and Corporate Finance Report Summary Bunzl plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Scienion AG:医療機器:M&Aディール及び事業提携情報
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Deoleo SA:企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Keck Seng Investments (Hong Kong) Ltd:企業の戦略・SWOT・財務情報
    Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report Summary Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • The Yokohama Rubber Co., Ltd.:企業の戦略・SWOT・財務情報
    The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fluor Corporation:企業の戦略・SWOT・財務情報
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shinkin Central Bank:企業の戦略・SWOT・財務情報
    Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report Summary Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Dolphin Drilling A.S.A. (FOE):企業の財務・戦略的SWOT分析
    Summary Dolphin Drilling ASA (Dolphin Drilling) is an oil and gas company that offers drilling contract and deep water services. The company's services include exploration and production services, repair services, fleet operations and management, pressure drilling, and deep water drilling services. …
  • Pharmascience Inc:企業のM&A・事業提携・投資動向
    Pharmascience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pharmascience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • LyondellBasell Industries NV (LYB)-石油・ガス分野:企業M&A・提携分析
    Summary LyondellBasell Industries N.V. (LyondellBasell) is a chemical company. It produces and sells petrochemicals, plastics and basic chemicals. The company also refines crude oil to convert into refined products such as gasoline, diesel and jet fuel. Its major chemical products include polyolefin …
  • Slavneft-Yaroslavnefteorgsintez (JNOS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Yaroslavnefteorgsintez (Slavneft-YANOS), a subsidiary of Slavneft, is an oil and gas company that offers refined petroleum products. The company offers products such as bitumen, motor gasoline, diesel fuel, jet fuel, motor oil, transmission oil, turbine oil, compressor oil, industri …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Patel Engineering Ltd:企業の戦略・SWOT・財務分析
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • C. R. Bard, Inc.:企業のM&A・事業提携・投資動向
    C. R. Bard, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's C. R. Bard, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Hudbay Minerals Inc
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Trovagene Inc (TROV):医療機器:M&Aディール及び事業提携情報
    Summary Trovagene Inc (Trovagene) is a clinical-stage cancer therapeutics company that focuses on improved cancer care using its technology in tumor genomics. Its lead product, PCM-075, is a polo-like kinase 1 (PLK1) inhibitor that helps treat solid tumor cancers and multiple hematologic malignancie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆